首页> 外国专利> METHOD OF DEFINING INDICATIONS FOR SURGICAL TREATMENT OF CENTRAL RETINAL VEIN BRANCH THROMBOSIS

METHOD OF DEFINING INDICATIONS FOR SURGICAL TREATMENT OF CENTRAL RETINAL VEIN BRANCH THROMBOSIS

机译:确定视网膜中央静脉分支血栓形成的手术治疗指征的方法

摘要

FIELD: medicine.;SUBSTANCE: invention concerns ophthalmology and can be applied in defining indications for surgical treatment of central retinal vein branch thrombosis (CRVBT) combined with macular edema (ME). Examination is performed at the acute stage of CRVBT before and in 10 days after medicament treatment. For original macula volume up to 8.0 mm3 and further volume preservation, reduction or increase by up to 0.12 mm3, favourable disease course is prognosed. For original macula volume over 8.0 mm3 and further absence of changes or edema increase by more than 0.12 mm3, adverse disease course is prognosed, and surgical treatment is considered necessary.;EFFECT: possible defining of indications for surgical treatment at acute stage of CRVBT, prognosis of surgical treatment result.;3 ex, 1 tbl
机译:领域:发明领域本发明涉及眼科,并且可以被用于定义与视网膜黄斑水肿(ME)结合的中央视网膜静脉分支血栓形成(CRVBT)的外科治疗的适应症。在药物治疗之前和之后10天的CRVBT急性期进行检查。对于原始黄斑体积最大为8.0 mm 3 并进一步保存,减少或增加最大体积为0.12 mm 3 ,预后良好。如果原始黄斑体积超过8.0 mm 3 ,并且进一步没有变化或水肿增加超过0.12 mm 3 ,则可预示不良的病程,因此需要手术治疗。效果:可能定义CRVBT急性期手术治疗的适应症,手术治疗结果的预后。3ex,1 tbl

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号